Scienmag

DECEMBER 9, 2020

Analysis of 200,000 groundwater samples reveals major mismatch in California groundwater data To ensure that California’s groundwater is sustainably managed in the future and over the long-term, current state definitions of what constitutes groundwater may need to be revised, according to research published this week in PNAS.

Big Data 81

Big Data Research Licensing Licensing 81

STAT News

MARCH 7, 2023

PALO ALTO — Step outside the quiet Stanford Medicine building where geneticist and prominent big data expert Mike Snyder has spent years poring over tiny samples of blood, and you can just see the outline of 1701 Page Mill Road, one of the original offices of Theranos. Continue to STAT+ to read the full story…

Big Data 119

Big Data Licensing Licensing Medicine 119

Pharma Marketing Network

SEPTEMBER 22, 2021

Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. The term can be used to describe several different technology-related healthcare applications that includes categories like EHR, mHealth, wearables Telehealth, big data, apps, and personalized medicine. Reena Kolar , Ph.D,

Big Data 52

Big Data Marketing Life Science Licensing 52

Pharma Marketing Network

SEPTEMBER 22, 2021

Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. The term can be used to describe several different technology-related healthcare applications that includes categories like EHR, mHealth, wearables Telehealth, big data, apps, and personalized medicine. Reena Kolar , Ph.D,

Big Data 40

Big Data Marketing Life Science Licensing 40

Pharmaceutical Technology

FEBRUARY 16, 2023

New-age technologies such as IoT, big data analytics, and 5G, as well as trends such as software-as-a-service (SaaS), cloud licensing, new frameworks of software, and high-speed digital standards, will revolutionise the future of analysis, testing and measurement equipment.

Engineer 130

Engineer Manufacturing Containment Production 130

Drug Discovery World

SEPTEMBER 7, 2022

This comment followed the announcement by AI-driven pharma-tech company Exscientia that Bristol Myers Squibb had chosen to in-license its immune-modulating drug candidate. . This platform is powered by patient molecular data in autoimmune diseases and artificial intelligence network science-based algorithms.

Drugs 52

Drugs Development Clinical Trials Clinical Trials 52

pharmaphorum

OCTOBER 16, 2020

These might be licensed drugs that could hold potential for a patent extension, or drugs which failed efficacy trials for an intended indication. In the quest to repurpose a drug for a rare condition, there is a need to look at any and all available data.

Clinical Trials 86

Clinical Trials Clinical Trials Trials Life Science 86